We are live on
!
Find out more
GCP
GSA Capital Partners Portfolio holdings
AUM
$1.59B
1-Year Est. Return
39.81%
This Fund
S&P 500
This Quarter
Est. Return
+3.87%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1B
AUM Growth
-$10.2M
(-1%)
Cap. Flow
-$19.8M
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
3.73%
Holding
2,077
New
647
Increased
422
Reduced
386
Closed
620
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wendy's
WEN
|
+$4.1M |
| 2 |
DMC
Del Monte Corp
DMC
|
+$3.08M |
| 3 |
Sonos
SONO
|
+$2.84M |
| 4 |
Idexx Laboratories
IDXX
|
+$2.8M |
| 5 |
John B. Sanfilippo & Son
JBSS
|
+$2.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$7.8M |
| 2 |
Hilton Worldwide
HLT
|
+$4.45M |
| 3 |
BJs Wholesale Club
BJ
|
+$4.02M |
| 4 |
Allegion
ALLE
|
+$4M |
| 5 |
NXP Semiconductors
NXPI
|
+$3.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.64% |
| 2 | Consumer Discretionary | 14.23% |
| 3 | Healthcare | 13.56% |
| 4 | Financials | 11.82% |
| 5 | Industrials | 11.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1401
Lloyds Banking Group
LYG
$91.3B
| $72K | 0.01% |
32,647
+6,830
| +26% | +$15.7K |
|
1402
ProQR Therapeutics
PRQR
$265M
| $71K | 0.01% |
+43,836
| New | +$85.6K |
|
1403
AbCellera Biologics
ABCL
$2.12B
| $69K | 0.01% |
+10,686
| New | +$72.9K |
|
|
AGEN
1404
Agenus
AGEN
$290M
| $69K | 0.01% |
2,167
-14,932
| -87% | -$478K |
|
1405
Globalstar
GSAT
$10.7B
| $69K | 0.01% |
4,243
+547
| +15% | +$8.77K |
|
1406
ReNew
RNW
$2.25B
| $69K | 0.01% |
+12,500
| New | +$68.4K |
|
|
TOUR
1407
Tuniu
TOUR
$55.6M
| $68K | 0.01% |
+4,109
| New | +$66.9K |
|
1408
Cue Biopharma
CUE
$114M
| $67K | 0.01% |
609
-1,828
| -75% | -$215K |
|
|
RJET
1409
Republic Airways Holdings
RJET
$1B
| $66K | 0.01% |
+1,734
| New | +$53.2K |
|
1410
Century Therapeutics
IPSC
$361M
| $65K | 0.01% |
+20,472
| New | +$66K |
|
|
OMIC
1411
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| $62K | 0.01% |
2,503
-4,687
| -65% | -$137K |
|
|
CANO
1412
DELISTED
Cano Health, Inc.
CANO
| $62K | 0.01% |
449
-2,781
| -86% | -$357K |
|
|
KNDI
1413
Kandi Technologies Group
KNDI
$65.5M
| $59K | 0.01% |
+14,844
| New | +$50.2K |
|
1414
UWM Holdings
UWMC
$434M
| $59K | 0.01% |
10,596
-67,951
| -87% | -$366K |
|
1415
Personalis
PSNL
$1.51B
| $57K | 0.01% |
+30,534
| New | +$69K |
|
1416
Spire Global
SPIR
$555M
| $57K | 0.01% |
+13,845
| New | +$73.7K |
|
|
SEEL
1417
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $57K | 0.01% |
+13
| New | +$45.1K |
|
1418
BRC Inc
BRCC
$250M
| $55K | 0.01% |
+10,563
| New | +$55.8K |
|
|
SACH
1419
Sachem Capital Corp
SACH
$39.8M
| $55K | 0.01% |
+15,843
| New | +$53.5K |
|
1420
Zevia
ZVIA
$111M
| $51K | 0.01% |
+11,794
| New | +$45.5K |
|
1421
Celularity
CELU
$20.3M
| $49K | ﹤0.01% |
9,183
+7,367
| +406% | +$47.2K |
|
1422
Marqeta
MQ
$1.66B
| $49K | ﹤0.01% |
+2,502
| New | +$45.4K |
|
1423
Pagaya Technologies
PGY
$1.78B
| $48K | ﹤0.01% |
+2,841
| New | +$35.4K |
|
|
PHX
1424
DELISTED
PHX Minerals
PHX
| $48K | ﹤0.01% |
+15,462
| New | +$44K |
|
|
IVAC
1425
DELISTED
Intevac Inc
IVAC
| $47K | ﹤0.01% |
+12,453
| New | +$66.8K |
|
Similar funds
NCL
DG
VNT
SS
GWANC
LCM
LCM
FDCP
GSA Capital Partners's Q2 2023 Portfolio in Review
As of Q2 2023, GSA Capital Partners held 2,077 positions worth $1B, down 1% from $1.01B the previous quarter. Its ten largest holdings account for 3.7% of the portfolio.
GSA Capital Partners's Q2 2023 filing shows 647 new, 422 increased, 386 reduced and 620 closed positions. Its largest new stake was Sonos: 160,082 shares worth $2.61M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $7.8M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- GSA Capital Partners's largest Q2 2023 buy was Sonos: 160,082 shares worth $2.61M.
- GSA Capital Partners added most to Wendy's in Q2 2023, an estimated $4.1M increase.
- GSA Capital Partners's biggest Q2 2023 reduction was Arlo Technologies, cutting an estimated $3.67M.
- GSA Capital Partners fully exited iShares 1-3 Year Treasury Bond ETF in Q2 2023, selling an estimated $7.8M.
- GSA Capital Partners's ten largest holdings make up 3.7% of its $1B portfolio in Q2 2023.
- GSA Capital Partners opened 647 new positions and closed 620 in Q2 2023.
- GSA Capital Partners's portfolio value fell 1% quarter-over-quarter to $1B.
Based on GSA Capital Partners's 13F filing for Q2 2023, filed 14 Aug 2023.